Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254605 · ClinicalTrials.gov registry record
Retinal Imaging in Patients With Inherited Retinal Degenerations
A clinical trial of Retinitis Pigmentosa, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00254605: Recruiting study of Retinitis Pigmentosa, sponsored by University of California, San Francisco.
NCT00254605 is a study of Retinitis Pigmentosa that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 400 participants, above the 251-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00254605, a study of Retinitis Pigmentosa, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).
Primary Outcome
The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.
Conditions Studied
Study Locations (1)
California
- Department of Ophthalmology Retinal Degenerations Clinic, UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-11-01 |
| Est. Completion | 2028-11 |
What NCT00254605 shows while recruiting
NCT00254605 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 251-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (59% higher).
The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 0 interventions.
NCT00254605 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00254605 about?
NCT00254605 is a clinical study titled "Retinal Imaging in Patients With Inherited Retinal Degenerations". The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).
What is the current status of trial NCT00254605?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2005-11-01. Estimated completion is 2028-11.
What conditions does trial NCT00254605 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa.
Who is sponsoring clinical trial NCT00254605?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00254605 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00254605's enrollment target sits among peer trials
400 8th of 37 higher than 30 of 37 other Retinitis Pigmentosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinitis Pigmentosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Promising ROd-cone DYstrophy Gene therapY
RECRUITING · Phase 1
-
High Resolution Retinal Imaging
RECRUITING
-
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
RECRUITING · Phase 2
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
Cell Collection to Study Eye Diseases
RECRUITING
-
Adaptive Optics Imaging of Outer Retinal Diseases
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI